FI970800A0 - Migreeninvastaisia indolijohdossuoloja - Google Patents

Migreeninvastaisia indolijohdossuoloja

Info

Publication number: FI970800A0
Authority: FI; Finland
Prior art keywords: migraine; indole derivative; derivative salts; salts; indole
Prior art date: 1994-08-27

Application number

FI970800A

Other languages

English (en)

Swedish (sv)

Other versions

FI970800L (fi

FI113768B (fi

Inventor

Valerie Denise Harding

Ross James Macrae

Ronald James Ogilvie

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-27

Filing date

1997-02-26

Publication date

1997-02-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10760474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970800(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-26 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

1997-02-26 Publication of FI970800A0 publication Critical patent/FI970800A0/fi

1997-02-26 Publication of FI970800L publication Critical patent/FI970800L/fi

2004-06-15 Application granted granted Critical

2004-06-15 Publication of FI113768B publication Critical patent/FI113768B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Reciprocating, Oscillating Or Vibrating Motors (AREA)

FI970800A 1994-08-27 1997-02-26 Migreeninvastaisia indolijohdossuoloja FI113768B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9417310A GB9417310D0 (en)	1994-08-27	1994-08-27	Therapeutic agents
GB9417310		1994-08-27
EP9501914		1995-05-17
PCT/EP1995/001914 WO1996006842A1 (en)	1994-08-27	1995-05-17	Salts of an anti-migraine indole derivative

Publications (3)

Publication Number	Publication Date
FI970800A0 true FI970800A0 (fi)	1997-02-26
FI970800L FI970800L (fi)	1997-02-26
FI113768B FI113768B (fi)	2004-06-15

Family

ID=10760474

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI970800A FI113768B (fi)	1994-08-27	1997-02-26	Migreeninvastaisia indolijohdossuoloja

Country Status (45)

Country	Link
US (2)	US6110940A (fi)
EP (1)	EP0776323B1 (fi)
JP (1)	JP2904588B2 (fi)
KR (1)	KR100228952B1 (fi)
CN (1)	CN1066727C (fi)
AP (1)	AP576A (fi)
AT (1)	ATE163182T1 (fi)
AU (1)	AU691005B2 (fi)
BG (1)	BG61840B1 (fi)
BR (1)	BRPI9503812B1 (fi)
CA (1)	CA2198599C (fi)
CO (1)	CO4410334A1 (fi)
CZ (1)	CZ287693B6 (fi)
DE (1)	DE69501620T2 (fi)
DK (1)	DK0776323T3 (fi)
DZ (1)	DZ1923A1 (fi)
EG (1)	EG23822A (fi)
ES (1)	ES2112650T3 (fi)
FI (1)	FI113768B (fi)
GB (1)	GB9417310D0 (fi)
GR (1)	GR3026475T3 (fi)
HR (1)	HRP950460B1 (fi)
HU (1)	HU227822B1 (fi)
IL (1)	IL115013A (fi)
IS (1)	IS1850B (fi)
LV (1)	LV11800B (fi)
MA (1)	MA23650A1 (fi)
MX (1)	MX9701538A (fi)
MY (1)	MY113733A (fi)
NO (1)	NO311297B1 (fi)
NZ (1)	NZ288210A (fi)
OA (1)	OA10600A (fi)
PE (1)	PE41596A1 (fi)
PL (1)	PL180867B1 (fi)
RO (1)	RO116400B1 (fi)
RU (1)	RU2159241C2 (fi)
SA (1)	SA95160156B1 (fi)
SI (1)	SI9520091B (fi)
SK (1)	SK282922B6 (fi)
TN (1)	TNSN95092A1 (fi)
TR (1)	TR199501061A2 (fi)
UA (1)	UA45980C2 (fi)
WO (1)	WO1996006842A1 (fi)
YU (1)	YU49287B (fi)
ZA (1)	ZA957142B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420529D0 (en)	1994-10-12	1994-11-30	Pfizer Ltd	Indoles
GB9706089D0 (en) *	1997-03-24	1997-05-14	Scherer Ltd R P	Pharmaceutical composition
GB9714081D0 (en) *	1997-07-03	1997-09-10	Pfizer Ltd	Pharmaceutical compositions
AU724728B2 (en) *	1997-07-03	2000-09-28	Pfizer Inc.	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
GB9816556D0 (en) *	1998-07-30	1998-09-30	Pfizer Ltd	Therapy
GB9825988D0 (en) *	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
GB9915231D0 (en)	1999-06-29	1999-09-01	Pfizer Ltd	Pharmaceutical complex
GB9923314D0 (en)	1999-10-01	1999-12-08	Pfizer Ltd	Acylation process
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
US7108970B2 (en)	2000-01-07	2006-09-19	Transform Pharmaceuticals, Inc.	Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
US6977723B2 (en)	2000-01-07	2005-12-20	Transform Pharmaceuticals, Inc.	Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
GB0008563D0 (en)	2000-04-07	2000-05-24	Cambridge Discovery Chemistry	Investigating different physical and/or chemical forms of materials
GB0018968D0 (en) *	2000-08-02	2000-09-20	Pfizer Ltd	Particulate composition
US20030166704A1 (en) *	2000-12-20	2003-09-04	Pfizer Inc.	New process
GB0031094D0 (en) *	2000-12-20	2001-01-31	Pfizer Ltd	New Process
US6579898B2 (en)	2001-03-01	2003-06-17	Pfizer Inc.	Compositions having improved bioavailability
EP1615635A1 (en)	2003-04-11	2006-01-18	Pfizer Limited	Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB0312478D0 (en) *	2003-05-30	2003-07-09	Pfizer Ltd	Improved process
US7132549B2 (en)	2003-05-30	2006-11-07	Pfizer Inc.	Process
US6927296B2 (en)	2003-07-23	2005-08-09	Pfizer Inc.	Process
GB0317229D0 (en) *	2003-07-23	2003-08-27	Pfizer Ltd	Improved process
US7241805B2 (en)	2005-06-27	2007-07-10	Biovail Laboratories, Inc.	Modified release formulations of a bupropion salt
RU2313340C1 (ru) *	2006-02-20	2007-12-27	Дмитрий Владимирович Зимин	Лекарственное средство, обладающее противомигренозным действием, и способ его изготовления
ATE502921T1 (de) *	2006-10-19	2011-04-15	Auspex Pharmaceuticals Inc	Substituierte indole
US20080139510A1 (en) *	2006-12-07	2008-06-12	Abe Rose	Treatment of migraine headaches with sublingual amino acids
EP1956018A1 (de) *	2007-02-06	2008-08-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Verfahren zur Herstellung eines Benzimidazolderivats
US20080287519A1 (en) *	2007-05-01	2008-11-20	Marioara Mendelovici	Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
EP2038273A1 (en) *	2007-05-29	2009-03-25	Plus Chemicals B.V.	A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole
EP2225224A2 (en) *	2007-12-17	2010-09-08	Actavis Group PTC EHF	Novel hemioxalate salt of eletriptan
WO2009142771A2 (en) *	2008-05-22	2009-11-26	Plus Chemicals, S.A.	Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3-[(r)-1- methyl-pyrrolidin-2- ylmethyl]-1h-indole and of eletriptan
CA2731041C (en)	2008-08-07	2016-09-06	Biovail Laboratories International Srl	Bupropion hydrobromide polymorphs
US20120027816A1 (en) *	2009-02-25	2012-02-02	Actavis Group Ptc Ehf	Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
WO2010116386A2 (en) *	2009-04-08	2010-10-14	Biophore India Pharmaceuticals Pvt. Ltd.	Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
IT1393700B1 (it)	2009-04-22	2012-05-08	F S I Fabbrica Italiana Sint	Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (en)	2009-06-25	2011-01-13	Matrix Laboratories Ltd	An improved process for the preparation of eletriptan and its salt thereof
US8754239B2 (en)	2010-01-19	2014-06-17	Sms Pharmaceuticals Limited	Process for preparing eletriptan hydrobromide having α-form
WO2014063752A1 (en)	2012-10-26	2014-05-01	Synthon Bv	Process for making crystalline form alpha of eletriptan hydrobromide
JP2019502761A (ja)	2016-01-21	2019-01-31	ラボラトリオスレヴィエセエレ	（（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2773875A (en) *	1952-03-28	1956-12-11	Hoffmann La Roche	Indole derivatives and method for producing same
GB886684A (en) *	1957-09-17	1962-01-10	Upjohn Co	Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) *	1958-02-25	1960-10-19	Rhone Poulenc Sa	New indole derivatives
US3037031A (en) *	1959-08-04	1962-05-29	Warner Lambert Pharmaceutical	Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) *	1960-03-01	1962-04-11	Roche Products Ltd	Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) *	1961-04-06	1964-08-12	Parke Davis & Co	Amine compounds and means of producing the same
US4092315A (en) *	1976-03-01	1978-05-30	Pfizer Inc.	Novel crystalline forms of prazosin hydrochloride
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
US4803218A (en) *	1982-09-29	1989-02-07	Mcneilab, Inc.	3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
DK158590D0 (da) *	1990-07-02	1990-07-02	Lundbeck & Co As H	Indolderivater
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
US5559246A (en) *	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
ES2104733T3 (es) *	1990-10-15	1997-10-16	Pfizer	Derivados de indol.
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5208248A (en) *	1991-01-11	1993-05-04	Merck Sharpe & Dohme, Ltd.	Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
ATE190608T1 (de) *	1991-11-25	2000-04-15	Pfizer	5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
GB9201038D0 (en) *	1992-01-16	1992-03-11	Glaxo Group Ltd	Chemical compounds
US5409941A (en) *	1992-02-03	1995-04-25	Pfizer Inc.	5-heteroyl indole derivatives
TW288010B (fi) *	1992-03-05	1996-10-11	Pfizer
UA27467C2 (uk) *	1992-04-07	2000-09-15	Пфайзер Інк.	ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
CZ282653B6 (cs) *	1992-04-10	1997-08-13	Pfizer Inc.	Acylaminoindolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
GB9207930D0 (en) *	1992-04-10	1992-05-27	Pfizer Ltd	Indoles
GB9208161D0 (en) *	1992-04-14	1992-05-27	Pfizer Ltd	Indoles
GB9210400D0 (en) *	1992-05-15	1992-07-01	Merck Sharp & Dohme	Therapeutic agents
FR2701026B1 (fr) *	1993-02-02	1995-03-31	Adir	Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP0695301B1 (en) *	1993-04-22	1996-10-30	Pfizer Limited	Indole derivatives as 5-ht1-like agonists for use in migraine
AP486A (en) *	1993-04-27	1996-04-16	Pfizer	Indole derivatives.
DK0716649T3 (da) *	1993-08-31	1999-02-08	Pfizer	5-Arylindolderivater

1994
- 1994-08-27 GB GB9417310A patent/GB9417310D0/en active Pending
1995
- 1995-05-17 WO PCT/EP1995/001914 patent/WO1996006842A1/en not_active Ceased
- 1995-05-17 ES ES95922465T patent/ES2112650T3/es not_active Expired - Lifetime
- 1995-05-17 RU RU97104885/04A patent/RU2159241C2/ru active
- 1995-05-17 DK DK95922465.0T patent/DK0776323T3/da active
- 1995-05-17 PL PL95318319A patent/PL180867B1/pl unknown
- 1995-05-17 SK SK248-97A patent/SK282922B6/sk not_active IP Right Cessation
- 1995-05-17 CN CN95194697A patent/CN1066727C/zh not_active Expired - Lifetime
- 1995-05-17 AT AT95922465T patent/ATE163182T1/de active
- 1995-05-17 RO RO97-00375A patent/RO116400B1/ro unknown
- 1995-05-17 CZ CZ1997563A patent/CZ287693B6/cs not_active IP Right Cessation
- 1995-05-17 NZ NZ288210A patent/NZ288210A/en not_active IP Right Cessation
- 1995-05-17 EP EP95922465A patent/EP0776323B1/en not_active Expired - Lifetime
- 1995-05-17 CA CA002198599A patent/CA2198599C/en not_active Expired - Lifetime
- 1995-05-17 AU AU27352/95A patent/AU691005B2/en not_active Expired
- 1995-05-17 KR KR1019970701281A patent/KR100228952B1/ko not_active Expired - Lifetime
- 1995-05-17 JP JP8508431A patent/JP2904588B2/ja not_active Expired - Lifetime
- 1995-05-17 DE DE69501620T patent/DE69501620T2/de not_active Expired - Lifetime
- 1995-05-17 SI SI9520091A patent/SI9520091B/sl unknown
- 1995-05-17 MX MX9701538A patent/MX9701538A/es active IP Right Grant
- 1995-05-17 US US08/776,680 patent/US6110940A/en not_active Expired - Lifetime
- 1995-05-17 UA UA97031432A patent/UA45980C2/uk unknown
- 1995-05-17 HU HU9701704A patent/HU227822B1/hu unknown
- 1995-07-27 AP APAP/P/1995/000754A patent/AP576A/en active
- 1995-08-14 SA SA95160156A patent/SA95160156B1/ar unknown
- 1995-08-16 TN TNTNSN95092A patent/TNSN95092A1/fr unknown
- 1995-08-21 MA MA23992A patent/MA23650A1/fr unknown
- 1995-08-21 IL IL11501395A patent/IL115013A/xx not_active IP Right Cessation
- 1995-08-23 CO CO95037815A patent/CO4410334A1/es unknown
- 1995-08-23 DZ DZ950104A patent/DZ1923A1/fr active
- 1995-08-23 PE PE1995277098A patent/PE41596A1/es not_active IP Right Cessation
- 1995-08-25 BR BRPI9503812A patent/BRPI9503812B1/pt not_active IP Right Cessation
- 1995-08-25 TR TR95/01061A patent/TR199501061A2/xx unknown
- 1995-08-25 YU YU56995A patent/YU49287B/sh unknown
- 1995-08-25 HR HR9417310.1A patent/HRP950460B1/xx not_active IP Right Cessation
- 1995-08-25 MY MYPI95002536A patent/MY113733A/en unknown
- 1995-08-25 ZA ZA9507142A patent/ZA957142B/xx unknown
- 1995-08-26 EG EG71195A patent/EG23822A/xx active
1996
- 1996-12-19 IS IS4401A patent/IS1850B/is unknown
1997
- 1997-02-20 BG BG101250A patent/BG61840B1/bg unknown
- 1997-02-26 FI FI970800A patent/FI113768B/fi not_active IP Right Cessation
- 1997-02-26 NO NO19970861A patent/NO311297B1/no not_active IP Right Cessation
- 1997-02-26 LV LVP-97-34A patent/LV11800B/en unknown
- 1997-02-27 OA OA60969A patent/OA10600A/en unknown
1998
- 1998-03-27 GR GR980400660T patent/GR3026475T3/el unknown
2000
- 2000-06-15 US US09/596,017 patent/US6380226B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR100228952B1 (ko)	1999-11-01
NO311297B1 (no)	2001-11-12
MX9701538A (es)	1997-05-31
HU227822B1 (en)	2012-03-28
SA95160156B1 (ar)	2005-05-30
DE69501620T2 (de)	1998-07-02
DK0776323T3 (da)	1998-03-30
ES2112650T3 (es)	1998-04-01
PL180867B1 (pl)	2001-04-30
LV11800B (en)	1997-10-20
SI9520091B (sl)	2004-10-31
AP576A (en)	1997-03-20
HRP950460B1 (en)	2000-02-29
IL115013A (en)	2000-11-21
AU691005B2 (en)	1998-05-07
IS4401A (is)	1996-12-19
CZ287693B6 (en)	2001-01-17
YU56995A (sh)	1998-07-10
CA2198599C (en)	2000-06-06
SK282922B6 (sk)	2003-01-09
CA2198599A1 (en)	1996-03-07
US6110940A (en)	2000-08-29
NO970861D0 (no)	1997-02-26
JPH09512283A (ja)	1997-12-09
RU2159241C2 (ru)	2000-11-20
NO970861L (no)	1997-02-26
NZ288210A (en)	1998-01-26
RO116400B1 (ro)	2001-01-30
US6380226B1 (en)	2002-04-30
PL318319A1 (en)	1997-06-09
EP0776323B1 (en)	1998-02-11
CZ56397A3 (cs)	1998-05-13
SK24897A3 (en)	1998-08-05
IL115013A0 (en)	1995-12-08
FI970800L (fi)	1997-02-26
ZA957142B (en)	1997-02-25
SI9520091A (sl)	1998-02-28
DZ1923A1 (fr)	2002-02-17
YU49287B (sh)	2005-03-15
FI113768B (fi)	2004-06-15
TNSN95092A1 (fr)	1996-02-06
BR9503812A (pt)	1996-04-16
BG101250A (en)	1997-09-30
EP0776323A1 (en)	1997-06-04
LV11800A (lv)	1997-06-20
AU2735295A (en)	1996-03-22
JP2904588B2 (ja)	1999-06-14
MY113733A (en)	2002-05-31
MA23650A1 (fr)	1996-04-01
OA10600A (en)	2000-04-06
HUT77310A (hu)	1998-03-30
KR970705557A (ko)	1997-10-09
PE41596A1 (es)	1996-10-12
HRP950460A2 (en)	1997-08-31
CN1066727C (zh)	2001-06-06
TR199501061A2 (tr)	1996-06-21
BG61840B1 (bg)	1998-07-31
IS1850B (is)	2003-02-07
GR3026475T3 (en)	1998-06-30
CN1155886A (zh)	1997-07-30
WO1996006842A1 (en)	1996-03-07
DE69501620D1 (de)	1998-03-19
CO4410334A1 (es)	1997-01-09
AP9500754A0 (en)	1995-07-31
BRPI9503812B1 (pt)	2017-04-18
UA45980C2 (uk)	2002-05-15
GB9417310D0 (en)	1994-10-19
EG23822A (en)	2007-09-19
ATE163182T1 (de)	1998-02-15

Publication	Publication Date	Title
FI970800A0 (fi)	1997-02-26	Migreeninvastaisia indolijohdossuoloja
FI972275A7 (fi)	1997-05-29	Indolijohdannainen
FI920480A7 (fi)	1992-02-04	Indolijohdannainen
FI944969A7 (fi)	1995-04-23	Indolijohdannaisia
DK43193A (da)	1993-10-17	Indolderivater
FI971234L (fi)	1997-05-23	Imidatsolijohdannainen
FI964624L (fi)	1996-11-19	Menetelmä duokarmysiinijohdannaisten stabiloimiseksi
DE69525418D1 (de)	2002-03-21	Benzimidazol-derivate
FI971510A7 (fi)	1997-04-11	Atsolijohdannainen
FI950568L (fi)	1995-08-11	5-heteroaryyli-indolijohdannaiset
ID24140A (id)	2000-07-06	Metode untuk sintesis derivatif-derivatif quinolin
NO970144L (no)	1997-01-20	Trifluormetylkinolinkarboksylsyre-derivat
FI971492L (fi)	1997-04-10	Indolijohdannaiset 5-HT1-tyyppisinä agonisteina
FI962496A7 (fi)	1996-06-14	3-substituoidut 1-aryyli-indoliyhdisteet
DK0725061T3 (da)	2000-10-02	Substituerede indolderivater
FI960730L (fi)	1996-02-16	Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina
NO972478D0 (no)	1997-05-30	System for signalisering via kraftledning
FI951047A7 (fi)	1995-09-10	Menetelmä indolijohdannaisten valmistamiseksi
FI955933L (fi)	1995-12-11	Abeo-ergoliinijohdannaiset 5HT1A-ligandeina
FI973382L (fi)	1997-08-18	Migreenin hoitoon käytettävä indolijohdannainen
IS1908B (is)	2003-12-31	Pýrrólidínýl metýl indól salt
KR960013550U (ko)	1996-05-17	편면용접용 마그네틱 지지구
FI953955A7 (fi)	1996-02-26	Sykloheksadieenijohdannaisia
DE59605373D1 (de)	2000-07-13	Substituierte Indol-Derivate
DK0755927T3 (da)	2001-10-29	Dimethylfurancarboxyanilidderivat

Legal Events

Date	Code	Title	Description
2006-05-05	PC	Transfer of assignment of patent	Owner name: PFIZER IRELAND PHARMACEUTICALS Free format text: PFIZER IRELAND PHARMACEUTICALS
2011-08-18	PC	Transfer of assignment of patent	Owner name: PFIZER IRELAND PHARMACEUTICALS Free format text: PFIZER IRELAND PHARMACEUTICALS
2015-06-22	MA	Patent expired

Date

Code

Title

Description

2006-05-05

Transfer of assignment of patent

Owner name: PFIZER IRELAND PHARMACEUTICALS

Free format text: PFIZER IRELAND PHARMACEUTICALS

2011-08-18